Across the health care industry, companies are responding to a new landscape defined by such initiatives as personalized medicine and comparative effectiveness research, as well as increased attention to risk mitigation and risk sharing, and evolving regulation. Analysis Group has developed a deep understanding of the health care sector: its unique institutional structure and market dynamics and the most critical business and regulatory challenges facing health care organizations.
We apply this analytical expertise to litigation, health economics and outcomes research, drug safety, business strategy, and public-policy engagements. Our clients include major pharmaceutical manufacturers, biotech and medical device companies, payers, managed care organizations, and government agencies.
Evidence and Comparative Effectiveness
Analysis Group outcomes researchers have developed innovative approaches to assessing the costs and value of therapies used to combat a range of diseases – amassing a comprehensive database of evidence in the process.
Our practice is distinguished by the way we integrate our capabilities in pharmacoeconomics, epidemiology, pricing and contracting strategies, and data sourcing and analysis to provide our clients with a comprehensive approach to problem solving.
RELATED MATERIALS